Lunit to Highlight New AI Evidence in Cancer Screening and Breast Density-Driven Risk Modeling at RSNA 2025
Eight oral presentations and six posters demonstrate advances in mammography, DBT performance, and density-informed risk modeling SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ — Lunit, a leading provider of AI for cancer diagnostics and precision oncology, today announced it will...
SNC and Applied Intuition Forge Alliance to Fast-track Battlefield Autonomy
Collaboration will fuse rapid software innovation with combat-tested systems integration to outpace global rivals MOUNTAIN VIEW, Calif. and SPARKS, Nev., Dec. 2, 2025 /PRNewswire/ — In a move signaling how quickly autonomous systems are reshaping modern warfare, physical intelligence leader...
Neurophet Appoints Josh Cohen, Former Executive from a Global Medical AI firm, as Head of Americas Business -- To Accelerate U.S. Market
Expert in sales and commercial strategy…Ex-Philips and previously served as Chief Commercial Officer (CCO) at Cortechs.ai To strengthen revenue growth of AI-based brain imaging solutions in the North American market and expand product deployment across healthcare institutions SEOUL, South Korea,...
Yuyu Pharma Announces Strategic Investment in Dalan Animal Health as Part of Accelerated Global Expansion in Animal Health
SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ — Yuyu Pharma announced today that it has completed a strategic investment in Dalan Animal Health, a U.S.-based biotechnology company advancing an innate immunity–based platform for developing vaccines for honeybees and shrimp. The...
2025 Understanding China Conference Opens in Guangzhou: Exploring Chinese Modernization Through the Lens of the 15th Five-Year Plan
GUANGZHOU, China, Dec. 2, 2025 /PRNewswire/ — Under the theme "New Plan, New Development, New Choices — Chinese Modernization and the New Vision of Global Governance," the 2025 Understanding China Conference (Guangzhou) brought together renowned global statesmen, scholars, industry leaders, and...
Worldwide Partners Releases "Confessions of a CMO," the First Global, Anonymous Study Revealing How CMOs are Evolving Under Pressure
DENVER, Dec. 2, 2025 /PRNewswire/ — Findings in Confessions of a CMO, a new global report by Worldwide Partners, challenge a common sentiment that the role of Chief Marketing Officer is diminishing. Through anonymous interviews with CMOs worldwide, Confessions of...
HoneyNaps' AI Sleep-Diagnosis Software SOMNUM™ Selected as a 2025 Next Generation World Class Product at MOTIR Certification Ceremony
Recognized at the official 2025 World Class Product of Korea Certification Ceremony held at Lotte Hotel World, Seoul Certification affirms SOMNUM’s potential to lead the global market within seven years HoneyNaps accelerates global expansion: "We aim to become Korea’s leading...
Neusoft Medical Systems Unveils World's First 8cm Wide-Coverage Photon-Counting CT and Other Premium Innovations at RSNA 2025
CHICAGO, Dec. 2, 2025 /PRNewswire/ — Neusoft Medical Systems Co., Ltd. ("Neusoft Medical"), a global leader in medical imaging, is showcasing its comprehensive portfolio of intelligent healthcare innovations at the Radiological Society of North America (RSNA) 2025 annual meeting. The highlight...
ATFX Connect Made a Strong Impact and Won The Best B2B Liquidity Provider (Prime of Prime) Award at FMLS:25
LONDON, Dec. 2, 2025 /PRNewswire/ — At the Finance Magnates London Summit 2025 (FMLS:25), ATFX Connect participated in several key institutional panels and was honoured with the Best B2B Liquidity Provider (Prime of Prime) award for its role in delivering liquidity solutions to...
Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy
SHANGHAI and HONG KONG, Dec. 2, 2025 /PRNewswire/ — Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications,...
Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health
∇ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. LONDON, Dec. 2, 2025 /PRNewswire/ — Accord Healthcare today announced the launch of Osvyrti (denosumab), a biosimilar to Prolia® (Amgen), and Jubereq (denosumab), a...
ChatBar AI and Anam Partner to Launch Human-Real AI Personas
A New Standard for Shareable AI Interaction SINGAPORE, Dec. 2, 2025 /PRNewswire/ — ChatBar AI and Anam today announced a strategic partnership that brings human-real AI personas to the web – combining Anam’s real-time audio-visual avatars with ChatBar AI’s patent-pending RAG engine...
Amaran Biotech's Vaccine Adjuvant AB-801 Receives FDA Drug Master File (DMF) Filing Acknowledgement
HSINCHU, Dec. 2, 2025 /PRNewswire/ — Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), announced that its self-developed, GMP-grade high-purity vaccine adjuvant AB-801 has received an Acknowledgement Letter from the U.S. Food and Drug Administration (FDA) for its...
MegazoneCloud Wins AWS APJ "Consulting Partner of the Year" Award for the Second Consecutive Year
– Simultaneously Receives APJ "Consulting Partner of the Year" and "Public Sector Consulting Partner of the Year" SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ — MegazoneCloud, a leading cloud managed service provider, has received two "Partner of the Year" awards...
Apacer Introduces ECO Series and AS714 Portable SSD with Next-Gen Creative Performance
TAIPEI, Dec. 2, 2025 /PRNewswire/ — In response to global sustainability trends, Apacer Technology Inc. has unveiled its new ECO Series portable storage products made from fully recycled plastic materials, alongside the AS714 Portable SSD, which combines which delivers mobile-ready convenience...
GC Biopharma's Varicella Vaccine Strain 'MAV/06' Listed in WHO Position Paper
Officially recognized by WHO as a standard varicella vaccine strain alongside Oka Interchangeability endorsed, enhancing global supply security YONGIN, South Korea, Dec. 2, 2025 /PRNewswire/ — GC Biopharma (006280.KS), a global biopharmaceutical company, today announced that its proprietary varicella vaccine strain MAV/06 has...